My priorities include ... reforming the health care system
Brett Guthrie will reform the health care system.
Occurrences
In this position, he leads the fight for lower costs in health care and keeping the government out of the doctor-patient relationship.
Evidence
legacy_unverified · Source version not recorded · locator unknown
On June 16, Guthrie and other E&C leaders asked NIH for details about alleged illegal transport of biological materials and requested a written response by June 30.
legacy_unverified · Source version not recorded · locator unknown
The Health Subcommittee held a hearing on health care transparency and discussed an updated Lower Costs, More Transparency Act plus prior-authorization data requirements.
legacy_unverified · Source version not recorded · locator unknown
The House vote on H.R. 3590, the Patient Protection and Affordable Care Act, passed 219-212. The Clerk lists Brett Guthrie, Republican of Kentucky, voting No.
legacy_unverified · Source version not recorded · locator unknown
The House vote on H.R. 1628, the American Health Care Act, passed 217-213. The Clerk lists Brett Guthrie, Republican of Kentucky, voting Aye.
legacy_unverified · Source version not recorded · locator unknown
The Senate vote on McConnell Amendment No. 667 to H.R. 1628, the American Health Care Act of 2017, resulted in Amendment Rejected, with 49 Yeas and 51 Nays.
legacy_unverified · Source version not recorded · locator unknown
The Energy and Commerce Committee report says H.R. 5663, the Safeguarding Therapeutics Act, was introduced on January 21, 2020, by Representatives Brett Guthrie and Eliot Engel and would extend FDA administrative destruction authority to medical devices.
legacy_unverified · Source version not recorded · locator unknown
Public Law 116-304 amended the Federal Food, Drug, and Cosmetic Act to authorize destruction of counterfeit devices and was approved January 5, 2021.
legacy_unverified · Source version not recorded · locator unknown
Public Law 115-271 states that the SUPPORT for Patients and Communities Act was enacted to provide for opioid use disorder prevention, recovery, and treatment, including Medicaid, Medicare, FDA, controlled-substance, and public health provisions.
legacy_unverified · Source version not recorded · locator unknown
The Health Subcommittee held a hearing on health care transparency and discussed an updated Lower Costs, More Transparency Act and prior-authorization data requirements.
legacy_unverified · Source version not recorded · locator unknown
Guthrie and other Energy and Commerce leaders asked NIH for details about alleged illegal transport of biological materials and requested a written response by June 30.
Assessments
Guthrie did not deliver a broad health care system reform attributable to him. A major reform, the Affordable Care Act, passed during his first House term, but he voted against it, so it cannot count as his fulfillment. He supported the 2017 American Health Care Act effort, but it failed in the Senate. He did, however, materially advance narrower health-related reforms, including the Guthrie-introduced Safeguarding Therapeutics Act, which became Public Law 116-304 in 2021, and broader opioid-related health legislation passed during his later House service. These amount to partial health care reform, not full system reform.
Guthrie has shown active committee-level involvement in health care oversight and transparency hearings, which indicates ongoing effort toward reform. However, the evidence does not show that he actually enacted or completed a health care system reform, so the promise cannot be judged delivered from the available record.